Prognostic Relevance of High-sensitivity Troponin in Patients With Acute Decompensated Heart Failure
NCT ID: NCT01429857
Last Updated: 2013-06-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
304 participants
OBSERVATIONAL
2010-06-30
2012-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Hospitalization on High-sensitivity Cardiac Troponin T Concentrations Depending on Disease Severity
NCT04963400
Distribution of Highly Sensitive Troponin in the Critically Unwell & Associated Mortality
NCT03630237
Prognostic Value of Elevated Troponins in Critical Illness Study: A Pilot Study
NCT02285686
Troponin- I Elevation Predicts Outcome After Thrombolysis in Stroke Patients
NCT03925298
Diagnostic Evaluation of Out-of-hospital High-sensitivity Troponin I in Patients Presenting Chest Pain
NCT04950244
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Systolic and / or diastolic heart failure
Exclusion Criteria
* Serum creatinine \>2.5 mg/dl
* Pulmonary embolism
18 Years
89 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Saarland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Christian Ukena
Dr. med. Christian Ukena
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Innere Medizin III - Kardiologie, Angiologie und Internistische Intensivtherapie
Homburg, Saarland, Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Poss J, Ukena C, Kindermann I, Ehrlich P, Fuernau G, Ewen S, Mahfoud F, Kriechbaum S, Bohm M, Link A. Angiopoietin-2 and outcome in patients with acute decompensated heart failure. Clin Res Cardiol. 2015 May;104(5):380-7. doi: 10.1007/s00392-014-0787-y. Epub 2014 Nov 19.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Hom-AHF-Troponin
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.